AMRX logo

Amneal Pharmaceuticals (AMRX) Cash and cash equivalents

annual cash & cash equivalents:

$110.55M+$19.01M(+20.77%)
December 31, 2024

Summary

  • As of today (May 29, 2025), AMRX annual cash & cash equivalents is $110.55 million, with the most recent change of +$19.01 million (+20.77%) on December 31, 2024.
  • During the last 3 years, AMRX annual cash & cash equivalents has fallen by -$137.24 million (-55.38%).
  • AMRX annual cash & cash equivalents is now -67.62% below its all-time high of $341.38 million, reached on December 31, 2020.

Performance

AMRX Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXbalance sheet metrics

quarterly cash & cash equivalents:

$59.19M-$51.37M(-46.46%)
March 31, 2025

Summary

  • As of today (May 29, 2025), AMRX quarterly cash & cash equivalents is $59.19 million, with the most recent change of -$51.37 million (-46.46%) on March 31, 2025.
  • Over the past year, AMRX quarterly cash & cash equivalents has increased by +$12.67 million (+27.23%).
  • AMRX quarterly cash & cash equivalents is now -86.91% below its all-time high of $452.10 million, reached on March 31, 2021.

Performance

AMRX quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

AMRX Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+20.8%+27.2%
3 y3 years-55.4%-71.9%
5 y5 years-26.9%-85.4%

AMRX Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-55.4%+325.6%-71.9%+127.8%
5 y5-year-67.6%+325.6%-86.9%+127.8%
alltimeall time-67.6%+325.6%-86.9%+127.8%

AMRX Cash and cash equivalents History

DateAnnualQuarterly
Mar 2025
-
$59.19M(-46.5%)
Dec 2024
$110.55M(+20.8%)
$110.55M(+49.4%)
Sep 2024
-
$74.01M(+69.1%)
Jun 2024
-
$43.77M(-5.9%)
Mar 2024
-
$46.52M(-49.2%)
Dec 2023
$91.54M(+252.4%)
$91.54M(+5.3%)
Sep 2023
-
$86.93M(-20.5%)
Jun 2023
-
$109.28M(-24.5%)
Mar 2023
-
$144.67M(+457.0%)
Dec 2022
$25.98M(-89.5%)
$25.98M(-70.3%)
Sep 2022
-
$87.33M(-5.0%)
Jun 2022
-
$91.98M(-56.3%)
Mar 2022
-
$210.48M(-15.1%)
Dec 2021
$247.79M
$247.79M(-18.1%)
DateAnnualQuarterly
Sep 2021
-
$302.65M(+8.7%)
Jun 2021
-
$278.31M(-38.4%)
Mar 2021
-
$452.10M(+32.4%)
Dec 2020
$341.38M(+125.8%)
$341.38M(+21.4%)
Sep 2020
-
$281.28M(+5.7%)
Jun 2020
-
$266.14M(-34.3%)
Mar 2020
-
$405.24M(+168.0%)
Dec 2019
$151.20M(-29.1%)
$151.20M(-28.9%)
Sep 2019
-
$212.74M(+287.6%)
Jun 2019
-
$54.89M(-14.2%)
Mar 2019
-
$63.95M(-70.0%)
Dec 2018
$213.39M(+187.7%)
$213.39M(+29.2%)
Sep 2018
-
$165.19M(+168.5%)
Jun 2018
-
$61.52M(-17.0%)
Dec 2017
$74.17M
$74.17M

FAQ

  • What is Amneal Pharmaceuticals annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals annual cash & cash equivalents year-on-year change?
  • What is Amneal Pharmaceuticals quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals quarterly cash & cash equivalents year-on-year change?

What is Amneal Pharmaceuticals annual cash & cash equivalents?

The current annual cash & cash equivalents of AMRX is $110.55M

What is the all time high annual cash & cash equivalents for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high annual cash & cash equivalents is $341.38M

What is Amneal Pharmaceuticals annual cash & cash equivalents year-on-year change?

Over the past year, AMRX annual cash & cash equivalents has changed by +$19.01M (+20.77%)

What is Amneal Pharmaceuticals quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of AMRX is $59.19M

What is the all time high quarterly cash & cash equivalents for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high quarterly cash & cash equivalents is $452.10M

What is Amneal Pharmaceuticals quarterly cash & cash equivalents year-on-year change?

Over the past year, AMRX quarterly cash & cash equivalents has changed by +$12.67M (+27.23%)
On this page